DCPH Deciphera Pharmaceuticals
- 25.380
- 0.0000.00%
- 25.310
- -0.070-0.28%
Deciphera Pharmaceuticals News
Catalyst Watch: Disney Earnings, Apple iPad Event and Fed Speakers Back on the Circuit
Biotech Stock Roundup: GILD's GSK' Q1 Earnings, DCPH Soars on Acquisition News & More
Express News | Guggenheim Downgrades Deciphera Pharmaceuticals to Neutral
Deep Dive Into Deciphera Pharmaceuticals Stock: Analyst Perspectives (5 Ratings)
In the last three months, 5 analysts have published ratings on Deciphera Pharmaceuticals (NASDAQ:DCPH), offering a diverse range of perspectives from bullish to bearish.The table below summarizes thei
Express News | Ono Pharmaceutical Co Ltd - to Acquire Deciphera for $25.60 per Share in Cash
JMP Downgrades Deciphera Pharmaceuticals to Market Perform
Deciphera Pharmaceuticals (DCPH) has an average investment rating of outperform among analysts polled by Capital IQ, with price targets ranging from $23 to $30. Price: 25.21, Change: -0.07, Percent Ch
ONO Enters Into A Definitive Agreement To Acquire Deciphera Pharmaceuticals >4528.TO
ONO Enters Into A Definitive Agreement To Acquire Deciphera Pharmaceuticals >4528.TO
Express News | Deciphera Pharmaceuticals Inc : Guggenheim Cuts to Neutral From Buy
Express News | Deciphera Pharmaceuticals, Inc. : Barclays Raises Target Price to $26 From $9
Express News | Deciphera Pharmaceuticals, Inc. : Barclays Raises to Equal-Weight From Underweight
Japan's Ono Pharma Says $2.4 Bln Deciphera Purchase 'First Step' for Global Expansion
US Equity Markets Close Higher Monday Ahead of Earnings, Fed Meeting This Week
US equity markets ended higher Monday as investors awaited key corporate earnings, including Apple (AAPL), Amazon.com (AMZN) and Eli Lilly (LLY), and the Federal Reserve's policy meeting this week. *
Janux Therapeutics Jumps as Much as 28% on Heels of Deciphera Buyout Deal
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Deciphera Pharmaceuticals, Inc. Buyout
Wilmington, Delaware--(Newsfile Corp. - April 29, 2024) - Rigrodsky Law, P.A. is investigating Deciphera Pharmaceuticals, Inc. ("Deciphera") (NASDAQ: DCPH) regarding possible breaches of fiduciary dut
Top Midday Gainers
Deciphera Pharmaceuticals (DCPH) said Monday that it agreed to be acquired by Japan-based ONO Pharmaceutical through a tender offer in a deal worth roughly $2.4 billion. Shares of Deciphera soared 72%
Acquisition Deal Propel Deciphera Pharmaceuticals (DCPH) Shares
Over the course of today's current session, Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) has seen a remarkable 72.39% increase in share price, closing at $25.25.
Trending Stocks Today: Collective Audience Shoots up 80.76%
April 29th - US stocks trending in regular trading hours.Gainers: $Collective Audience(CAUD.US)$ soars 80.76% to $0.71 with a turnover of $102.48 million. $Deciphera Pharmaceuticals(DCPH.US)$ shoots u
Sector Update: Health Care
Health care stocks were higher Monday afternoon, with the NYSE Health Care Index rising 0.4% and the Health Care Select Sector SPDR Fund (XLV) up 0.3%. The iShares Biotechnology ETF (IBB) rose 1.9%. I
Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Clever Leaves Holdings Inc. (NASDAQ:CLVR) fell sharply during Monday's session after the company announced that it will voluntarily delist its common shares from the Nasdaq and deregister it
FLGC, BTOG and CAUD Among Mid-day Movers
Analysis
Price Target
No Data
